摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4'-(4-aminobenzyl)-2,2-dimethyl-2,3-dihydro-5'H-spiro[chromene-4,2'-[1,4]oxazinan]-5'-one | 918151-10-7

中文名称
——
中文别名
——
英文名称
4'-(4-aminobenzyl)-2,2-dimethyl-2,3-dihydro-5'H-spiro[chromene-4,2'-[1,4]oxazinan]-5'-one
英文别名
4'-(4-aminobenzyl)-2,2-dimethyl-2,3-dihydro-5'H-spiro[chromene-4,2'-[1,4]-oxazinane]-5'-one;4'-(4-aminobenzyl)-2,2-dimethyl-2,3-dihydro-5'H-spiro[chromen-4,2'-[1,4]oxazinan]-5'-one;4'-[(4-aminophenyl)methyl]-2,2-dimethylspiro[3H-chromene-4,6'-morpholine]-3'-one
4'-(4-aminobenzyl)-2,2-dimethyl-2,3-dihydro-5'H-spiro[chromene-4,2'-[1,4]oxazinan]-5'-one化学式
CAS
918151-10-7
化学式
C21H24N2O3
mdl
——
分子量
352.433
InChiKey
QOASNZDEQMFYSX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    26
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    64.8
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Synthesis and pharmacological characterization of mitochondrial KATP channel openers with enhanced mitochondriotropic effects
    作者:Lara Testai、Simona Sestito、Alma Martelli、Era Gorica、Lorenzo Flori、Vincenzo Calderone、Simona Rapposelli
    DOI:10.1016/j.bioorg.2020.104572
    日期:2021.2
    Mitochondria play a key role for deciding fate of cells and thus are considered an attractive target for pharmacological interventions focused on containment of myocardial ischemia/reperfusion (I/R) injury. Notably, the activation of mitochondrial potassium (mitoK) channels produces a mild depolarization of mitochondrial membrane, that contributes to reduce the driving force to calcium uptake and prevents
    线粒体在决定细胞命运方面起着关键作用,因此被认为是专注于抑制心肌缺血/再灌注 (I/R) 损伤的药理干预的有吸引力的目标。值得注意的是,线粒体钾 (mitoK) 通道的激活导致线粒体膜轻度去极化,这有助于降低钙摄取的驱动力并阻止线粒体过渡膜孔 (MPTP) 的形成;这些事件是抗缺血性心脏保护作用的基础。然而,理想的 mitoK 通道开放剂应该具备在线粒体水平传递的基本要求;因此,为了改善先前表征的螺环苯并吡喃 F81 的线粒体递送,已经开发了新化合物。三原三苯鏻(TPP+ ) - F81 ( 1 – 3 ) 的衍生物评估了它们对分离的心脏线粒体和心脏 H9c2 细胞系的心脏保护活性。在体内梗塞模型中进一步研究了化合物1。这项工作证实了应用于 mitoKATP 开启剂的 TPP +策略可以促进线粒体递送并增强钾通道线粒体激活剂的心脏保护作用。
  • Spirocyclic Benzopyran-Based Derivatives as New Anti-ischemic Activators of Mitochondrial ATP-Sensitive Potassium Channel
    作者:Maria C. Breschi、Vincenzo Calderone、Maria Digiacomo、Mariaelisa Manganaro、Alma Martelli、Filippo Minutolo、Simona Rapposelli、Lara Testai、Federica Tonelli、Aldo Balsamo
    DOI:10.1021/jm800956g
    日期:2008.11.13
    Heart mitochondrial ATP-sensitive potassium channels mito-K-ATP channels) are deeply implicated in the self-defense mechanism of ischemic preconditioning. Therefore, exogenous molecules activating these channels are considered as a promising pharmacological tool to reduce the myocardial injury deriving from ischemia/reperfusion events. This paper reports the synthesis and pharmacological evaluation of original spiromorpholine- and spiromorpholone-benzopyran, derivatives, with the aim to obtain selective activators of mito-K-ATP channels. Some compounds of this series showed appreciable cardioprotective effects on rat isolated and perfused hearts, Submitted to ischemia/reperfusion cycles. The selective mito-K-ATP channel blocker 5-hydroxydecanoic acid antagonized the anti-ischemic activity, indicating a clear implication of this pharmacological target. Furthermore, these effects were not associated with significant hypotensive and vasorelaxing properties, which represent one of the main limiting factors for the clinical use of nonselective T K-ATP-openers against myocardial ischemia.
  • WO2008/7210
    申请人:——
    公开号:——
    公开(公告)日:——
  • New Benzopyran-Based Openers of the Mitochondrial ATP-Sensitive Potassium Channel with Potent Anti-Ischemic Properties
    作者:Maria C. Breschi、Vincenzo Calderone、Alma Martelli、Filippo Minutolo、Simona Rapposelli、Lara Testai、Federica Tonelli、Aldo Balsamo
    DOI:10.1021/jm061228l
    日期:2006.12.1
    spirocyclic substituent at the C4 carbon of the benzopyran molecular nucleus may improve the cardioprotective properties against ischemia. Some of the new compounds (1b, 2b, and 4b) exhibited interesting anti-ischemic properties without affecting significantly the blood pressure parameters.
    这项研究旨在评估有限数量的苯并吡喃化合物是否在苯并吡喃分子核的C4碳原子上插入富含电子的螺环取代基,以改善对局部缺血的心脏保护作用。一些新化合物(1b,2b和4b)显示出令人感兴趣的抗缺血特性,而不会显着影响血压参数。
查看更多